M. Ando

Rejuvenating Effector/Exhausted CAR T Cells to Stem Cell Memory–Like CAR T Cells By Resting Them in the Presence of CXCL12 and the NOTCH Ligand

A. Yoshimura, S. Shichino, W. Tomisato, 2021, Cancer research communications.

Phase II study of nimustine hydrochloride (ACNU) plus paclitaxel for refractory small cell lung cancer.

A. Gemma, Kunihiko Kobayashi, K. Isobe, 2009, Lung cancer.

Memory B cells and memory T cells induced by SARS-CoV-2 booster vaccination or infection show different dynamics and efficacy to the Omicron variant

H. Saya, A. Yoshimura, K. Fukunaga, 2022, bioRxiv.

Serum levels of KL-6 are useful biomarkers for severe radiation pneumonitis.

H. Ohmatsu, R. Kakinuma, Y. Nishiwaki, 2001, Lung cancer.

Memory B Cells and Memory T Cells Induced by SARS-CoV-2 Booster Vaccination or Infection Show Different Dynamics and Responsiveness to the Omicron Variant.

H. Saya, A. Yoshimura, K. Fukunaga, 2022, Journal of immunology.

A Protein Kinase D Inhibitor Suppresses AKT on T cells and Antagonizes Cancer Immunotherapy by Anti-PD-1.

N. Onishi, A. Yoshimura, S. Chikuma, 2022, International Immunology.

The Irreversible FLT3 Inhibitor FF-10101 Is Active Against a Diversity of FLT3 Inhibitor Resistance Mechanisms.

A. Logan, Catherine C. Smith, Kimberly C. Lin, 2022, Molecular cancer therapeutics.

Phase 1 first-in-human study of irreversible FLT3 inhibitor FF-10101-01 in relapsed or refractory acute myeloid leukemia.

M. Levis, A. Fathi, J. Altman, 2021 .